Rathbones Group PLC Cara Therapeutics, Inc. Transaction History
Rathbones Group PLC
- $19.7 Billion
- Q4 2024
A detailed history of Rathbones Group PLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Rathbones Group PLC holds 20,164 shares of CARA stock, worth $114,934. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,164
Previous 20,164
-0.0%
Holding current value
$114,934
Previous $6,000
1950.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CARA
# of Institutions
10Shares Held
826KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY745KShares$4.24 Million0.0% of portfolio
-
American Portfolios Advisors Holbrook, NY40.4KShares$230,4220.02% of portfolio
-
Rothschild Investment Corp10.6KShares$60,4200.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ8.83KShares$50,3480.0% of portfolio
-
Ahrens Investment Partners LLC700Shares$3,9900.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $306M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...